+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Screening - Global Market Trajectory & Analytics

  • ID: 4804177
  • Report
  • April 2021
  • Region: Global
  • 180 pages
  • Global Industry Analysts, Inc
Global Drug Screening Market to Reach $11.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Drug Screening estimated at US$6.3 Billion in the year 2020, is projected to reach a revised size of US$11.3 Billion by 2027, growing at a CAGR of 8.8% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 7.9% CAGR and reach US$7.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 10.7% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 8.3% CAGR

The Drug Screening market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Select Competitors (Total 42 Featured):
  • Alere, Inc.
  • Alfa Scientific Designs, Inc.
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Lifeloc Technologies, Inc.
  • Mpd, Inc.
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 13: World Current & Future Analysis for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Breath by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 16: World Current & Future Analysis for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Oral Fluid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 19: World Current & Future Analysis for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Hair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 22: World Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
  • Table 25: USA Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: USA Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 27: USA 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 28: USA Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 29: USA Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 30: USA 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 31: Canada Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 33: Canada 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 34: Canada Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 35: Canada Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 36: Canada 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 37: Japan Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Japan Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 39: Japan 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 40: Japan Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 41: Japan Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 42: Japan 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 43: China Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: China Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 45: China 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 46: China Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 47: China Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 48: China 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 49: Europe Current & Future Analysis for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 50: Europe Historic Review for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 51: Europe 15-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 52: Europe Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 53: Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 54: Europe 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 55: Europe Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 57: Europe 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 58: France Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 59: France Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 60: France 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 61: France Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: France Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 63: France 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 64: Germany Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 65: Germany Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 66: Germany 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 67: Germany Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Germany Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 69: Germany 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 70: Italy Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 71: Italy Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 72: Italy 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 73: Italy Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 74: Italy Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 75: Italy 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 76: UK Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 77: UK Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 78: UK 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 79: UK Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 80: UK Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 81: UK 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 82: Rest of Europe Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 83: Rest of Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 84: Rest of Europe 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 85: Rest of Europe Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 86: Rest of Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 87: Rest of Europe 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 88: Asia-Pacific Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 89: Asia-Pacific Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 90: Asia-Pacific 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 91: Asia-Pacific Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 92: Asia-Pacific Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 93: Asia-Pacific 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
  • Table 94: Rest of World Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 95: Rest of World Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 96: Rest of World 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2020 & 2027
  • Table 97: Rest of World Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 98: Rest of World Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 99: Rest of World 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown
Adroll
adroll